The goal of the High Resolution Imaging Shared Facility (HRISF) is to enable the detection and imaging of molecules in biological systems, which is a vital tool in cancer research .To accomplish this mission, the facility provides access to instrumentation and expertise that supports both fundamental mechanistic studies, and the development and testing of new biomarkers and treatments for cancer. The HRISF was founded in the late 1990s with funds from an NCRR Shared Instrument Grant, a UAB Health Services Foundation award, and significant institutional resources.
The specific aims of the HRISF are: 1) To provide consultation in the design and conduct of Confocal Laser Scanning Microscopy (CLSM),Multi-platform Laser Scanning Microscopy (MPLSM), and digital imaging experiments 2) To provide technical assistance for imaging studies, including consultation concerning specimen preparation, and assistance with image acquisition. 3) To provide assistance in post-acquisition data analysis and interpretation. 4) To work with members of the CCC to identify new ways that these imaging technologies can be employed to enhance their research productivity and overall competitiveness. 5) To adapt sophisticated new imaging techniques, including fluorescence lifetime measurements and 2""^ harmonic generation, to the research problems of CCC members. Many of the instruments required to image molecules at the sub-cellular level would require an investment in expensive equipment and in expertise that generally lie outside the capabilities of any single laboratory. A centralized facility provides access both to cutting-edge technology to acquire images and to personnel with the experience to guide CCC investigators in optimal use of the technology. The HRISF served 55 CCC investigators during the current funding period and their use accounted for 46% of the total facility usage. During this same period, support from the CCC accounted for less than 23% of the total annual operating costs of the facility.

Public Health Relevance

To understand the fundamental mechanisms of the biology of cancer cells, it is important to be able to determine the precise location and behavior of the proteins inside the cells. The High Resolution Imaging Facility provides instrumentation and expertise to support fundamental mechanistic studies of cancer biology. Furthermore, the facility resources support the identification of new biomarkers that are essential for cancer diagnosis and for the development of novel treatments for cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-41
Application #
8732235
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-03-28
Project End
2016-03-31
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
41
Fiscal Year
2013
Total Cost
$155,782
Indirect Cost
$68,572
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Carson, Tiffany L; Hardy, Claudia M; Greene, Eva et al. (2014) Considerations for bio-specimen collection among black women residing in the rural Deep South participating in a cancer prevention study. J Community Genet 5:257-63
Fauci, Janelle M; Sabbatino, Francesco; Wang, Yangyang et al. (2014) Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96. Gynecol Oncol 132:203-10
Devine, D J; Rostas, J W; Metge, B J et al. (2014) Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-*/SMAD signaling. Oncogene 33:2620-8
Kim, Hyunki; Rigell, Christopher J; Zhai, Guihua et al. (2014) Antagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers. Mol Imaging Biol 16:85-94
Saini, Reshu; Hoyt, Kenneth (2014) Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis. Imaging Med 6:41-52
Sonpavde, Guru; Willey, Christopher D; Sudarshan, Sunil (2014) Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma. Expert Opin Investig Drugs 23:305-15
Shim, Eun-Hee; Livi, Carolina B; Rakheja, Dinesh et al. (2014) L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discov 4:1290-8
Gan, Yujun; Buckels, Ashiya; Liu, Ying et al. (2014) Human GH receptor-IGF-1 receptor interaction: implications for GH signaling. Mol Endocrinol 28:1841-54
Johnson, David H; Wilson, W William; DeLucas, Lawrence J (2014) Protein solubilization: a novel approach. J Chromatogr B Analyt Technol Biomed Life Sci 971:99-106
Ramos, Theresa N; Bullard, Daniel C; Barnum, Scott R (2014) ICAM-1: isoforms and phenotypes. J Immunol 192:4469-74

Showing the most recent 10 out of 364 publications